Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q1 2024 (← Previous) (Next →)
Filing Date: May 15, 2024
Total Value: $498M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ELI LILLY & CO | 115,000 | $89.47M | 18.0% | — | — | Put | 532457958 |
| NVO | NOVO-NORDISK A S | 691,743 | $88.82M | 17.9% | $113.34 | — | ADR | 670100205 |
| LLY | ELI LILLY & CO | 92,593 | $72.03M | 14.5% | $527.62 | +33.1% | COM | 532457108 |
| MRK | MERCK & CO INC | 379,200 | $50.04M | 10.1% | $96.84 | +19.6% | COM | 58933Y105 |
| VKTX | VIKING THERAPEUTICS INC | 433,580 | $35.55M | 7.1% | $21.06 | +111.2% | COM | 92686J106 |
| ABBV | ABBVIE INC | 90,821 | $16.54M | 3.3% | $137.22 | +18.1% | COM | 00287Y109 |
| — | INTRA-CELLULAR THERAPIES INC | 210,096 | $14.54M | 2.9% | $65.98 | — | COM | 46116X101 |
| ARGX | ARGENX SE | 34,238 | $13.48M | 2.7% | $387.47 | — | SPONSORED ADR | 04016X101 |
| AZN | ASTRAZENECA PLC | 190,752 | $12.92M | 2.6% | $69.76 | — | SPONSORED ADR | 046353108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 28,900 | $12.08M | 2.4% | $422.74 | 0.0% | COM | 92532F100 |
| AXSM | AXSOME THERAPEUTICS INC | 87,848 | $7.01M | 1.4% | $73.77 | +13.8% | COM | 05464T104 |
| OCUL | OCULAR THERAPEUTIX INC | 724,685 | $6.595M | 1.3% | $4.58 | +54.9% | COM | 67576A100 |
| CYTK | CYTOKINETICS INC | 89,525 | $6.277M | 1.3% | $62.59 | +23.6% | COM NEW | 23282W605 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 45,000 | $6.206M | 1.2% | $117.13 | +16.6% | COM | 64125C109 |
| IRON | DISC MEDICINE INC | 87,040 | $5.419M | 1.1% | $64.84 | 0.0% | COM | 254604101 |
| PCVX | VAXCYTE INC | 76,255 | $5.209M | 1.0% | $56.71 | +22.1% | COM | 92243G108 |
| APGE | APOGEE THERAPEUTICS INC | 61,590 | $4.093M | 0.8% | $39.68 | +10.0% | COM | 03770N101 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 85,765 | $4.015M | 0.8% | $39.13 | 0.0% | COM | 22663K107 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 124,440 | $3.6M | 0.7% | $25.24 | +7.8% | COM | 74366E102 |
| DYN | DYNE THERAPEUTICS INC | 119,488 | $3.392M | 0.7% | $22.62 | 0.0% | COM | 26818M108 |
| INSM | INSMED INC | 118,236 | $3.208M | 0.6% | $26.68 | +4.9% | COM PAR $.01 | 457669307 |
| — | SPRINGWORKS THERAPEUTICS INC | 53,930 | $2.654M | 0.5% | $49.22 | — | COM | 85205L107 |
| ASND | ASCENDIS PHARMA A/S | 15,894 | $2.403M | 0.5% | $151.17 | — | SPONSORED ADR | 04351P101 |
| IDYA | IDEAYA BIOSCIENCES INC | 52,492 | $2.303M | 0.5% | $43.00 | 0.0% | COM | 45166A102 |
| — | MERUS N V | 50,171 | $2.259M | 0.5% | $45.03 | — | COM | N5749R100 |
| — | VERONA PHARMA PLC | 130,790 | $2.104M | 0.4% | $19.88 | — | SPONSORED ADS | 925050106 |
| — | ALPINE IMMUNE SCIENCES INC | 51,714 | $2.05M | 0.4% | $39.64 | — | COM | 02083G100 |
| CRL | CHARLES RIV LABS INTL INC | 6,905 | $1.871M | 0.4% | $226.63 | +5.4% | COM | 159864107 |
| JANX | JANUX THERAPEUTICS INC | 47,949 | $1.805M | 0.4% | $21.78 | 0.0% | COM | 47103J105 |
| SLNO | SOLENO THERAPEUTICS INC | 40,924 | $1.752M | 0.4% | $45.23 | 0.0% | COM | 834203309 |
| XENE | XENON PHARMACEUTICALS INC | 40,000 | $1.722M | 0.3% | $46.00 | 0.0% | COM | 98420N105 |
| ARVN | ARVINAS INC | 40,000 | $1.651M | 0.3% | $43.69 | 0.0% | COM | 04335A105 |
| PLRX | PLIANT THERAPEUTICS INC | 100,000 | $1.49M | 0.3% | $23.67 | -30.3% | COM | 729139105 |
| MREO | MEREO BIOPHARMA GROUP PLC | 421,359 | $1.39M | 0.3% | $3.30 | — | SPON ADS | 589492107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 54,285 | $1.284M | 0.3% | $20.30 | 0.0% | ORDINARY SHARES | N62509109 |
| — | RAPT THERAPEUTICS INC | 137,308 | $1.233M | 0.2% | $11.25 | — | COM | 75382E109 |
| SLN | SILENCE THERAPEUTICS PLC | 52,476 | $1.133M | 0.2% | $21.60 | — | ADS | 82686Q101 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 51,500 | $1.065M | 0.2% | $11.57 | +113.9% | COM NEW | 30233G209 |
| ANNX | ANNEXON INC | 147,485 | $1.057M | 0.2% | $5.19 | 0.0% | COM | 03589W102 |
| VERA | VERA THERAPEUTICS INC | 24,298 | $1.048M | 0.2% | $35.64 | 0.0% | CL A | 92337R101 |
| MGNX | MACROGENICS INC | 64,007 | $942K | 0.2% | $15.11 | 0.0% | COM | 556099109 |
| KURA | KURA ONCOLOGY INC | 39,478 | $842K | 0.2% | $19.44 | 0.0% | COM | 50127T109 |
| IMVT | IMMUNOVANT INC | 21,397 | $691K | 0.1% | $36.80 | -0.9% | COM | 45258J102 |
| BMEA | BIOMEA FUSION INC | 35,452 | $530K | 0.1% | $27.12 | -39.3% | COM | 09077A106 |
| LRMR | LARIMAR THERAPEUTICS INC | 58,190 | $442K | 0.1% | $7.79 | 0.0% | COM | 517125100 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,557 | $416K | 0.1% | $235.62 | 0.0% | COM | 558868105 |
| — | EFFECTOR THERAPEUTICS INC | 25,000 | $360K | 0.1% | — | — | Call | 28202V907 |
| — | POSEIDA THERAPEUTICS INC | 86,002 | $274K | 0.1% | $3.19 | — | COM | 73730P108 |
| — | GRITSTONE BIO INC | 95,170 | $245K | 0.0% | $1.95 | — | COM | 39868T105 |